Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand
information for practice,
Many patients develop tumour recurrence within a few years after undergoing surgical resection of gastrointestinal stromal…